Portage Biotech Inc. (PRTG)

NASDAQ: PRTG · Real-Time Price · USD

5.61

+0.19 (3.51%)

Aug 4, 2025, 2:26 PM - Market open

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 4, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	13	15	11	54	88	338	Upgrade
Market Cap Growth	36.57%	36.57%	-79.28%	-38.67%	-74.06%	238.01%	Upgrade
Enterprise Value	11	13	5	40	108	382	Upgrade
Last Close Price	5.42	9.25	11.27	61.80	131.40	559.40	Upgrade
PB Ratio	-	-18.40	3.35	0.71	0.53	2.29	Upgrade
P/TBV Ratio	-	-	2.77	0.71	1.13	5.82	Upgrade
Debt / Equity Ratio	-	-	0.01	-	-	0.00	Upgrade
Quick Ratio	1.53	1.53	1.76	5.78	30.09	1.08	Upgrade
Current Ratio	2.02	2.02	2.67	7.33	31.71	1.54	Upgrade
Return on Equity (ROE)	-541.81%	-541.81%	-191.51%	-86.92%	-12.25%	-11.72%	Upgrade
Return on Assets (ROA)	-92.69%	-92.69%	-21.34%	-6.71%	-5.27%	-4.40%	Upgrade
Return on Capital (ROIC)	-363.77%	-363.77%	-28.97%	-8.19%	-6.22%	-5.13%	Upgrade
Earnings Yield	-54.79%	-44.46%	-676.02%	-194.53%	-19.24%	-4.69%	Upgrade
FCF Yield	-44.23%	-35.89%	-128.29%	-22.46%	-7.71%	-1.27%	Upgrade
Buyback Yield / Dilution	-22.21%	-22.21%	-20.10%	-23.43%	-11.31%	-7.13%	Upgrade

Updated Nov 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q